Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

BMS-587101: new LFA-1 antagonist in phase II study for psoriasis

March 30, 2006

Curis achieves preclinical milestone in hair growth program with P&G

March 23, 2006

Preliminary 48-week from phase III psoriasis trial of ISA-247

March 22, 2006

PPARgamma agonists claimed in Galderma patent for skin disorders

March 21, 2006

Dimethylcurcumin claimed as a potential topical agent for acne vulgaris

March 14, 2006

Preliminary clinical data on efalizumab for the treatment of oral lichen planus reported

March 10, 2006

Shionogi and Galderma reach initial sales agreement for adapalene gel

March 10, 2006

Pivotal study begins for KeraPac in diabetic foot ulcers

March 9, 2006

S-236 cream may be used to promote barrier repair in atopic dermatitis

March 8, 2006

Studies assess antibacterial, antiinflammatory activity of AN-0128

March 7, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...